Sustained response to lenalidomide for early relapsed marginal zone lymphoma.
Ibrahimi S, Vidal G, Mukherjee S, Alhyari L, Scordino T, Cherry M. Sustained response to lenalidomide for early relapsed marginal zone lymphoma. Blood Cells Mol Dis. 2018 07; 71:53-54.